Oncotarget: Inhibitory effects of Tomivosertib in acute myeloid leukemia

(Impact Journals LLC) These Oncotarget findings demonstrate that Tomivosertib exhibits potent anti-leukemic properties on AML cells and support the development of clinical translational efforts involving the use of this drug.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news